GB0214013D0 - Pharmaceutical product - Google Patents

Pharmaceutical product

Info

Publication number: GB0214013D0
Authority: GB; United Kingdom
Prior art keywords: pharmaceutical product; pharmaceutical; product
Prior art date: 2002-06-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0214013.5A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Euro Celtique SA

Original Assignee

Euro Celtique SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-18

Filing date

2002-06-18

Publication date

2002-07-31

2002-06-18 Application filed by Euro Celtique SA filed Critical Euro Celtique SA

2002-06-18 Priority to GBGB0214013.5A priority Critical patent/GB0214013D0/en

2002-07-31 Publication of GB0214013D0 publication Critical patent/GB0214013D0/en

2003-06-18 Priority to ES03732728.5T priority patent/ES2470975T3/en

2003-06-18 Priority to AU2003240111A priority patent/AU2003240111A1/en

2003-06-18 Priority to PCT/GB2003/002622 priority patent/WO2003105812A1/en

2003-06-18 Priority to JP2004512718A priority patent/JP2005533783A/en

2003-06-18 Priority to EP03732728.5A priority patent/EP1513508B1/en

2003-06-18 Priority to US10/517,858 priority patent/US20050249798A1/en

2009-09-04 Priority to US12/554,483 priority patent/US8586083B2/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Medicinal Preparation (AREA)

GBGB0214013.5A 2002-06-18 2002-06-18 Pharmaceutical product Ceased GB0214013D0 (en)

Priority Applications (8)

Application Number	Priority Date	Filing Date	Title
GBGB0214013.5A GB0214013D0 (en)	2002-06-18	2002-06-18	Pharmaceutical product
ES03732728.5T ES2470975T3 (en)	2002-06-18	2003-06-18	Gastroretentive medication delivery system comprising an extruded hydratable polymer
AU2003240111A AU2003240111A1 (en)	2002-06-18	2003-06-18	Gastroretentive drug delivery system comprising an extruded hydratable polymer
PCT/GB2003/002622 WO2003105812A1 (en)	2002-06-18	2003-06-18	Gastroretentive drug delivery system comprising an extruded hydratable polymer
JP2004512718A JP2005533783A (en)	2002-06-18	2003-06-18	Gastric retention drug delivery system comprising an extruded hydratable polymer
EP03732728.5A EP1513508B1 (en)	2002-06-18	2003-06-18	Gastroretentive drug delivery system comprising an extruded hydratable polymer
US10/517,858 US20050249798A1 (en)	2002-06-18	2003-06-18	Gastroretentive drug delivery system comprising an extruded hydratable polymer
US12/554,483 US8586083B2 (en)	2002-06-18	2009-09-04	Gastroretentive drug delivery system comprising an extruded hydratable polymer

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0214013.5A GB0214013D0 (en)	2002-06-18	2002-06-18	Pharmaceutical product

Publications (1)

Publication Number	Publication Date
GB0214013D0 true GB0214013D0 (en)	2002-07-31

Family

ID=9938815

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0214013.5A Ceased GB0214013D0 (en)	2002-06-18	2002-06-18	Pharmaceutical product

Country Status (7)

Country	Link
US (2)	US20050249798A1 (en)
EP (1)	EP1513508B1 (en)
JP (1)	JP2005533783A (en)
AU (1)	AU2003240111A1 (en)
ES (1)	ES2470975T3 (en)
GB (1)	GB0214013D0 (en)
WO (1)	WO2003105812A1 (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8025899B2 (en)	2003-08-28	2011-09-27	Abbott Laboratories	Solid pharmaceutical dosage form
US8377952B2 (en)	2003-08-28	2013-02-19	Abbott Laboratories	Solid pharmaceutical dosage formulation
EP3101034A1 (en)	2004-02-12	2016-12-07	Morphotek, Inc.	Monoclonal antibodies that specifically bind to folate receptor alpha
US8298574B2 (en)	2006-01-18	2012-10-30	Intec Pharma Ltd.	Method and apparatus for forming delivery devices for oral intake of an agent
US8795721B2 (en)	2006-12-18	2014-08-05	Eatlittle Inc.	Device for delivery of a substance
DK2167069T3 (en)	2007-05-23	2011-11-21	Amcol International Corp	Cholesterol-interacting layered phyllosilicates and methods for reducing hypercholesterolemia in a mammal
US8969514B2 (en)	2007-06-04	2015-03-03	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
WO2008151257A2 (en)	2007-06-04	2008-12-11	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2009149279A2 (en)	2008-06-04	2009-12-10	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2730603C (en)	2008-07-16	2019-09-24	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en)	2010-09-15	2017-04-11	Synergy Pharmaceuticals, Inc.	Formulations of guanylate cyclase C agonists and methods of use
US20130143867A1 (en)	2011-12-02	2013-06-06	Sychroneuron Inc.	Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2014039951A1 (en)	2012-09-10	2014-03-13	Novartis Ag	Enteral pharmaceutical compositions
US9545446B2 (en)	2013-02-25	2017-01-17	Synergy Pharmaceuticals, Inc.	Agonists of guanylate cyclase and their uses
WO2014151200A2 (en)	2013-03-15	2014-09-25	Synergy Pharmaceuticals Inc.	Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en)	2013-03-15	2016-01-20	Synergy Pharmaceuticals Inc.	Agonists of guanylate cyclase and their uses
WO2014197744A1 (en)	2013-06-05	2014-12-11	Synchroneuron, Inc.	Acamprosate formulations, methods of using the same, and combinations comprising the same
CN106061494A (en)	2013-10-10	2016-10-26	辛纳吉制药公司	Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions
KR20170015389A (en)	2014-06-02	2017-02-08	테바 파마슈티컬 인더스트리즈 리미티드	Expandable gastroretentive dosage form
US20170266112A1 (en)	2014-06-11	2017-09-21	Massachusetts Institute Of Technology	Residence structures and related methods
AU2015274453A1 (en)	2014-06-11	2017-01-12	Massachusetts Institute Of Technology	Enteric elastomers
US9617230B2 (en)	2014-12-22	2017-04-11	Farmington Pharma Development	Creatine prodrugs, compositions and methods of use thereof
EP4512394A3 (en)	2015-06-03	2025-10-22	Triastek, Inc.	Dosage forms and use thereof
WO2017070612A1 (en) *	2015-10-23	2017-04-27	Lyndra, Inc.	Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
ES2963058T3 (en)	2015-12-08	2024-03-25	Lyndra Therapeutics Inc	Geometric configurations for gastric residence systems
EP3402804A1 (en)	2016-01-11	2018-11-21	Synergy Pharmaceuticals Inc.	Formulations and methods for treating ulcerative colitis
US12109305B2 (en)	2016-05-27	2024-10-08	Lyndra Therapeutics, Inc.	Materials architecture for gastric residence systems
EP3518902A4 (en)	2016-09-30	2020-07-08	Lyndra, Inc.	STOMACH RESTORATION SYSTEMS FOR RETARD RELEASE OF ACTIVE SUBSTANCES
JP7071748B2 (en)	2016-12-02	2022-05-19	クレキシオバイオサイエンシーズエルティーディー．	Gastric retention system
EP3573602A4 (en)	2017-01-26	2020-09-16	Triastek, Inc.	DOSAGE FORMS WITH CONTROLLED RELEASE IN SPECIFIC GASTROINTESTINAL LOCATIONS
AU2018279853B2 (en)	2017-06-09	2024-07-04	Nortiva Bio, Inc.	Gastric residence systems with release rate-modulating films
AU2018375199B2 (en)	2017-12-01	2023-03-30	Ultragenyx Pharmaceutical Inc.	Creatine prodrugs, compositions and methods of use thereof
US11547839B2 (en)	2017-12-04	2023-01-10	Clexio Biosciences Ltd.	Long acting gastric residence system
WO2019126214A1 (en)	2017-12-18	2019-06-27	Tris Pharma, Inc.	Pharmaceutical composition comprising ghb gastro-retentive raft forming systems having trigger pulse drug release
CA3097737A1 (en)	2017-12-18	2019-06-27	Tris Pharma, Inc.	Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
WO2019126215A1 (en)	2017-12-18	2019-06-27	Tris Pharma, Inc.	Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
CN112004520B (en)	2017-12-18	2024-08-23	特瑞斯制药公司	Modified release pharmaceutical powder compositions comprising a gastric raft formation system with triggered pulsatile drug release
CN116270513A (en)	2018-01-09	2023-06-23	南京三迭纪医药科技有限公司	A combination oral pharmaceutical dosage form comprising a fixed-dose ADHD non-stimulant and an ADHD stimulant
EP3820442A1 (en)	2018-07-11	2021-05-19	Rheinische Friedrich-Wilhelms-Universität Bonn	Floating gastric retentive drug delivery system
EP3968980A1 (en)	2019-05-14	2022-03-23	Clexio Biosciences Ltd.	Treatment of nocturnal symptoms and morning akinesia in subjects with parkinson's disease
CA3160660A1 (en) *	2019-11-08	2021-05-14	Lyndra Therapeutics, Inc.	Formulations for release-rate modulating films for gastric residence systems
JP2023536456A (en) *	2020-07-29	2023-08-25	ザ・セカント・グループ・エルエルシー	Shape-induced controlled release and retention comprising structures containing cross-linked poly(glycerol sebacate)
TW202233162A (en) *	2020-10-30	2022-09-01	大陸商南京三迭紀醫藥科技有限公司	Drug dosage forms for stomach retention
WO2022195476A1 (en)	2021-03-15	2022-09-22	Clexio Biosciences Ltd.	Gastroretentive devices for assessment of intragastric conditions
CN121038779A (en)	2023-02-03	2025-11-28	特瑞斯制药公司	A nightly low-sodium hydroxybutyrate composition

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2531134A (en) *	1946-03-12	1950-11-21	American Cyanamid Co	Dimethyl phthalate solution of acetyl peroxide as catalyst for trifluorochloroethylene polymerization
GB1601923A (en) *	1977-06-09	1981-11-04	Beecham Group Ltd	Sustained release compositions
US4451260A (en) *	1982-03-26	1984-05-29	Minnesota Mining And Manufacturing Company	Sustained release oral medicinal delivery device
US5439966A (en) *	1984-07-12	1995-08-08	National Research Development Corporation	Polyethylene oxide temperature - or fluid-sensitive shape memory device
US4720384A (en) *	1985-05-03	1988-01-19	E. I. Du Pont De Nemours And Company	Manufacture of hollow fine tubular drug delivery systems
US4673565A (en) *	1985-05-03	1987-06-16	E. I. Du Pont De Nemours And Company	Pharmaceutical compositions containing hollow fine tubular drug delivery systems
JPS6226215A (en)	1985-05-10	1987-02-04	メルク　エンド　カムパニ−　インコ−ポレ−テツド	Drug transmission device keeping in stomach during controlled time
US4767627A (en) *	1985-05-29	1988-08-30	Merck & Co., Inc.	Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) *	1985-05-29	1988-07-19	Merck & Co., Inc.	Drug delivery device which can be retained in the stomach for a controlled period of time
DE3775880D1 (en) *	1986-09-18	1992-02-20	London School Of Pharmacy Innovations Ltd., London, Gb
DE3803482A1 (en) *	1988-02-05	1989-08-17	Lohmann Therapie Syst Lts	FLOATING ORAL THERAPEUTIC SYSTEM
GB9025372D0 (en)	1990-11-22	1991-01-09	Nat Res Dev	Pharmaceutical dosage forms
US5582837A (en) *	1992-03-25	1996-12-10	Depomed, Inc.	Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
US6312726B1 (en)	1993-08-20	2001-11-06	Nippon Shinyaku Co., Ltd.	Gastric remaining preparation, swollen molding, and production process
PL179910B1 (en) *	1994-05-06	2000-11-30	Pfizer	Controlled release dosage form containing azithromycin
US5965161A (en) *	1994-11-04	1999-10-12	Euro-Celtique, S.A.	Extruded multi-particulates
WO1998055107A1 (en) *	1997-06-06	1998-12-10	Depomed, Inc.	Gastric-retentive oral drug dosage forms for controlled release of highly soluble drugs
ATE285226T1 (en) *	1997-08-11	2005-01-15	Alza Corp	GASTRIC RETENTION FORM FOR PROLONGED RELEASE OF AN ACTIVE INGREDIENT

2002
- 2002-06-18 GB GBGB0214013.5A patent/GB0214013D0/en not_active Ceased
2003
- 2003-06-18 ES ES03732728.5T patent/ES2470975T3/en not_active Expired - Lifetime
- 2003-06-18 EP EP03732728.5A patent/EP1513508B1/en not_active Expired - Lifetime
- 2003-06-18 JP JP2004512718A patent/JP2005533783A/en active Pending
- 2003-06-18 AU AU2003240111A patent/AU2003240111A1/en not_active Abandoned
- 2003-06-18 WO PCT/GB2003/002622 patent/WO2003105812A1/en not_active Ceased
- 2003-06-18 US US10/517,858 patent/US20050249798A1/en not_active Abandoned
2009
- 2009-09-04 US US12/554,483 patent/US8586083B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
WO2003105812A1 (en)	2003-12-24
EP1513508B1 (en)	2014-03-12
JP2005533783A (en)	2005-11-10
US8586083B2 (en)	2013-11-19
US20050249798A1 (en)	2005-11-10
US20090324694A1 (en)	2009-12-31
EP1513508A1 (en)	2005-03-16
ES2470975T3 (en)	2014-06-24
AU2003240111A1 (en)	2003-12-31

Publication	Publication Date	Title
GB0214013D0 (en)	2002-07-31	Pharmaceutical product
EP1615615A4 (en)	2007-03-07	Pharmaceutical products
GB2386116B (en)	2005-12-14	Product dispensers
GB0218625D0 (en)	2002-09-18	Pharmaceutical compounds
AU2003280324A1 (en)	2004-06-18	Pharmaceutical allergen product
GB0305133D0 (en)	2003-04-09	Product
ZA200509099B (en)	2006-08-30	Stabilized pharmaceutical product
GB0215775D0 (en)	2002-08-14	Pharmaceutical compounds
GB0230152D0 (en)	2003-02-05	Product
AU307054S (en)	2006-05-29	Pharmaceutical packaging
GB0315889D0 (en)	2003-08-13	Stable pharmaceutical products
GB0206505D0 (en)	2002-05-01	Pharmaceutical combination
GB0201520D0 (en)	2002-03-13	Pharmaceutical uses
AU155083S (en)	2004-04-02	Pharmaceutical packaging
AU155150S (en)	2004-04-13	Pharmaceutical packaging
PL373409A1 (en)	2005-08-22	Pharmaceutical combination
GB0316360D0 (en)	2003-08-13	Pharmaceutical product
GB0317475D0 (en)	2003-08-27	Product
GB0210289D0 (en)	2002-06-12	Product
GB0206338D0 (en)	2002-05-01	Product selection
GB0203907D0 (en)	2002-04-03	Product
GB0204680D0 (en)	2002-04-17	Pharmaceutical product
GB0210293D0 (en)	2002-06-12	Product
GB0210297D0 (en)	2002-06-12	Product
PL365363A1 (en)	2004-08-23	Goldsmithery product

Legal Events

Date	Code	Title	Description
2003-12-24	AT	Applications terminated before publication under section 16(1)